Sudeep Pharma's Initial Public Offering (IPO) opened on November 21, aiming to raise ₹895 crore. On the first day, the IPO was subscribed 33%, with Non-Institutional Investors (NII) at 52% and retail investors at 43%. The price band is ₹563-593 per share. Unlisted shares traded at a Grey Market Premium (GMP) of around 20%, indicating expectations for a strong listing.